Безопасен ли elaidoyl tripeptide-37 при беременности?

Related ingredients

Frequently asked questions

Безопасен ли elaidoyl tripeptide-37 при беременности?

No harmonised CLP classification, no SCCS or CIR safety assessment flagging reproductive hazard, and no peer‑reviewed reproductive/toxicity studies located for elaidoyl tripeptide‑37 in the referenced databases. No specific evidence of reproductive toxicity or endocrine activity was identified (sources searched: ECHA Annex VI, SCCS, CIR, PubMed, ECHA dossiers, PubChem, CosIng, EWG). Given the lack of data and absence of regulatory flags, default hazard and mechanism scores are 0.

Безопасен ли elaidoyl tripeptide-37 при грудном вскармливании?

No data on lactation transfer or effects on breastfed infants were identified in authoritative sources. No regulatory or peer‑reviewed signals indicating risk; therefore hazard and mechanism scored 0. Exposure for breastfeeding considered comparable to maternal topical exposure (no data to indicate high systemic availability).

Безопасен ли elaidoyl tripeptide-37 для кожи малыша?

No infant‑specific safety data found. As a peptide acylated with an elaidoyl (fatty) group, molecular size and polarity suggest limited dermal absorption in adults, but infant skin has higher permeability; following the guidance, exposure score increased by +1 for 0–3 yr skin despite no evidence of hazard/mechanism. No data show increased infant hazard or specific mechanisms.

Как VeriMom оценивает elaidoyl tripeptide-37?

VeriMom оценивает elaidoyl tripeptide-37 в 100/100 (без известных рисков) на основе EU CosIng, классификаций ECHA и исследований PubMed.

Какие безопасные альтернативы elaidoyl tripeptide-37 при беременности?

См. наш список безопасных альтернатив elaidoyl tripeptide-37 с аналогичной функцией и классификацией без известных рисков.